Ignite Creation Date:
2024-05-06 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05328440
Status:
RECRUITING
Last Update Posted:
2023-09-25
First Post:
2022-03-14
Brief Title:
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2 Advanced Breast CancerDAP-Her-02
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasms |
Keywords:
| Name | View |
|---|---|
| HER2-positive MBC | View |